Cochrane Review Group

Hepato-Biliary

132 systematic reviews in Hepato-Biliary ask 1,521 questions. 19.9% have no studies to answer them, 57.6% rest on very low certainty evidence and 5.7% reach moderate or high certainty.

Reviews

132

Questions

1,521

current versions

No studies

19.9%

Moderate or high

5.7%

No studies 303 · 19.9%Ungraded 39 · 2.6%Very low 876 · 57.6%Low 216 · 14.2%Moderate 65 · 4.3%High 22 · 1.4%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Search questions in Hepato-Biliary

Thinnest evidence

All no studies and very low questions

Question	Effect	Evidence	Status / GRADE
Microwave coagulation in addition to conventional transarterial chemoembolisation vs conventional transarterial chemoembolisation alone All‐cause mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies
Microwave coagulation vs conventional surgery Health‐related quality of life · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies
Microwave coagulation vs conventional surgery Any adverse events or complications · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	1 study · 30 participants	Very low
Microwave coagulation vs conventional surgery Disease‐free survival · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	1 study · 30 participants	Very low
Microwave coagulation vs conventional surgery Failure to clear liver metastases · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies
Microwave coagulation vs conventional surgery Recurrence of liver metastases · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies
Microwave coagulation vs radiofrequency ablation All‐cause mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	RR 0.62 [0.26, 1.47]	1 study · 50 participants	Very low
Microwave coagulation vs radiofrequency ablation Time to mortality (overall survival) · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	HR 0.63 [0.23, 1.73]	1 study · 50 participants	Very low
Microwave coagulation vs radiofrequency ablation Health‐related quality of life · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies
Microwave coagulation vs radiofrequency ablation Any adverse events or complications · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	RR 0.19 [0.01, 3.67]	1 study · 50 participants	Very low
Microwave coagulation vs radiofrequency ablation Disease‐free survival · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies
Microwave coagulation in addition to conventional transarterial chemoembolisation vs conventional transarterial chemoembolisation alone Time to mortality · people with liver metastases Microwave coagulation for liver metastases (2024) · Cochrane	no estimate extracted	NR	No studies